Lumigan
FDA Label NDC 0023-9187

The following Structured Product Label (SPL) was submitted to the FDA by Allergan, Inc. for the product Lumigan (NDC 0023-9187). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding principal display panel - 0.3 mg/1 ml carton label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Principal Display Panel - 0.3 Mg/1 Ml Carton Label

®ALLERGAN

LUMIGAN®
(bimatoprost
ophthalmic solution)

0.03%

3 mL

sterile Rx only

®allerganlumigan®(bimatoprostophthalmic Solution) 0.03% 3 mLsterile Rx Only (Lumigan 03 01)

ALLERGAN™

Rx

bimatoprost
ophthalmic solution

0.03%

LUMIGAN™

3 mL

sterile

Allergan™rx Bimatoprostophthalmicsolution 0.03% Lumigan™3 mLsterile For External Use Only (Lumigan 03 02)

®ALLERGAN

LUMIGAN™

Rx

(BIMATOPROST
OPHTHALMIC
SOLUTION)
0.03%

3 mL

sterile

®allerganlumigan™(bimatoprostophthalmicsolution)0.03% 3 mLsterile (Lumigan 03 03)

®ALLERGAN

LUMIGAN™

(BIMATOPROST
OPHTHALMIC
SOLUTION)
0.03%

K

3 mL

sterile

®allerganlumigan™(bimatoprostophthalmicsolution)0.03% K3 mLsterile (Lumigan 03 04)

®ALLERGAN

LUMIGAN™

(bimatoprost
ophthalmic solution
SOLUTION)
0.03%

3 mL

sterile

®allerganlumigan™(bimatoprostophthalmicsolution)0.03% 3 mLsterile (Lumigan 03 05)

®ALLERGAN

LUMIGAN™

(bimatoprost 0.03%
Ophthalmic solution

3 mL

sterile

®allerganlumigan™(bimatoprostophthalmicsolution)0.03% 3 mLsterile (Lumigan 03 06)

* Please review the disclaimer below.